Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
- Add to watchlist
- Create an alert
- This stock can be held in a
n/a
n/a
1,034.00p
1,092.89
1,024.00p
n/a
715.00p
-7.95%
18.00p (1.79%) Previous:
18.00p
n/a
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 9.28% | 1 year 1Y | 27.36% |
---|---|---|---|
1 month 1M | 5.46% | 2 years 2Y | 19.21% |
3 months 3M | 10.94% | 3 years 3Y | 29.28% |
6 months 6M | 33.86% | 5 years 5Y | 47.98% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | Yes |
Ongoing charge: | 1.30% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £412m |
Gross gearing: | 12% |
Market capitalisation:Market cap.: | £336m |
Shares in issue: | 33.42 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 1,092.89 |
---|---|
Latest actual NAV: | 1,094.18 |
Latest actual NAV date: | 2 May 2024 |
Premium/Discount: | -7.95% |
12m average Premium/Discount: | -7.50% |
NAV frequency: | Daily |
Security | Weight |
---|---|
Amgen Inc | 9.30% |
Biogen Inc | 7.86% |
Regeneron Pharmaceuticals Inc | 4.99% |
Vaxcyte Inc Ordinary Shares | 4.68% |
Sarepta Therapeutics Inc | 4.49% |
Ionis Pharmaceuticals Inc | 4.32% |
Argen X SE EUR0.10 | 3.85% |
Quantumpharm Inc (Xtalpi) - Pfd | 3.31% |
Scholar Rock Holding Corp | 3.27% |
Apellis Pharmaceuticals Inc | 2.97% |
Sector | Weight |
---|---|
Healthcare | 100.55% |
Country | Weight |
---|---|
United States | 91.49% |
China | 5.73% |
Germany | 1.72% |
Canada | 1.60% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2024 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.